Sarcoidosis vasculitis and diffuse lung diseases

Published: 2013-09-01

Editorial

Section 1: Update on idiopathic pulmonary fibrosis: epidemiology, natural history, disease staging and pathogenesis

Epidemiology of idiopathic pulmonary fibrosis in Europe – an update

I. Annesi-Maesano, H. Nunes, B. Duchemann, et al.
Abstract 314 | PDF Downloads 73

Page 6-12

Classification, natural history and staging of idiopathic pulmonary fibrosis

V. Poletti, J. Egan
Abstract 220 | PDF Downloads 56

Page 13-20

Section 2: Update on idiopathic pulmonary fibrosis: pathophysiology and future perspectives

Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity

B. Crestani
Abstract 106 | PDF Downloads 30

Page 27-32

Section 3: Management of idiopathic pulmonary fibrosis and implications for clinical practice - A case study series

Management of idiopathic pulmonary fibrosis and pulmonary hypertension

K. Schulze
Abstract 77 | PDF Downloads 35

Page 33-36

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis

C. Vancheri
Abstract 79 | PDF Downloads 43

Page 37-39

Pirfenidone treatment in a patient with IPF and possible initial hypersensitivity pulmonitis

F. Cinetto, C. Agostini
Abstract 102 | PDF Downloads 35

Page 40-43

Management of a patient with familial idiopathic pulmonary fibrosis

S. Böing, S. George, L. Hagmeyer
Abstract 74 | PDF Downloads 52

Page 48-51

Long-term management of IPF with pirfenidone – a clinical case study with 5 years follow-up

L. Richeldi, G. Sgalla, S. Cerri
Abstract 168 | PDF Downloads 46

Page 52-62

Conclusions